Fundraising Fox
BrightEdge
Impact investorAtlanta · Pre-Seed–Late Stage · 15 people tracked
Find your way into BrightEdge
Each arrow is one introduction. Sign up to fill in the first one.
Ask Avinash Joshi to introduce you to Stephen Curtis
You →Avinash · together at 2M Companies, Inc. →Stephen
Ask Jamie Chen to introduce you to Steve Curtis
You →Jamie · together at BrightEdge →Steve
Ask Sam Okafor to introduce you to Farnaz Bakhshi
You →Sam · together at BrightEdge →Farnaz
- Amy Berg6 people can intro you
- Calum Daly6 people can intro you
- Barbra Kocsis6 people can intro you
Sign up to find every way you can get introduced to BrightEdge
- Your email: who you already know at BrightEdge, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the BrightEdge team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
BrightEdge operates at the intersection of investment and innovation to catalyze scientific, social, and sustainable impact across the cancer care continuum. As the innovation and impact investment arm of the American Cancer Society, it leverages ACS's legacy in cancer research and patient support to identify and invest in scalable, actionable solutions addressing critical areas of unmet need in oncology. The firm targets three-dimensional impact: advancing scientific discovery and ethical product design, reducing health disparities by directing private investment toward technology-enabled solutions, and building sustainability by generating financial returns that can be reinvested into ACS's lifesaving programs.
Source: firm website, verified Sep 25, 2026.
Team · 15 people
from the firm's website & curated
Founder mafia
2 people who came through BrightEdge went on to found or lead other companies.
What they invest in
from 7 of 9 portfolio companiesHealthtech ×7Biotech ×6Medical Devices ×4Deep Tech ×3Digital Health ×2Data & Infrastructure ×1Impact & Social Good ×1
HQs:United States×6
Investments · 9 tracked
founders shown can be your intro pathBy year:2026 · 22025 · 12024 · 12023 · 12022 · 27 dated
The American Cancer Society is a nonprofit organization that provides cancer research updates, screening and prevention guidance, and community engagement opportunities.
Digital HealthHealthtechImpact & Social Good
Co-investorsBlue Ledge CapitalFred Hutchinson Cancer Research Center
CatenaBio develops precision conjugation technology using native amino acids to enable biotherapeutic fusions of small molecules, nucleic acids, enzymes, and cells.
BiotechDeep TechHealthtechMedical DevicesBerkeley, US
Marco Lobba(Founder)inMatthew Francis(Founder)inMarco Lobba, Ph.D.(Founder)in
Co-investorsCALIFORNIA INNOVATIONCivilization Ventures Management, LlcCreative Destruction Lab (CDL)FREEFLOWIaso VenturesJude Gomila+13 more
CellCentric develops inobrodib, a small-molecule oral p300/CBP inhibitor intended to treat multiple myeloma and other cancers.
BiotechHealthtechMedical Devices
Azim Surani(Co-founder)
Co-investorsAvego BioScience CapitalFuture Planet CapitalHBM Healthcare InvestmentsHBM PartnersRA CapitalSofinnova Partners+2 more
Machine learning and data platform for understanding how diseases fight back and resist therapies
David Li(Founder)in
Co-investorsHAWKTAILJude GomilaValkyrieAxial VCHOF CapitalObvious Ventures+3 more
Modifi Bio presents itself as a research-focused biopharmaceutical company developing medicines and vaccines.
BiotechHealthtechNew Haven, US
Ranjit Bindra(Director)inKingson Lin(Cofounder)inKevin L. Rakin(Executive Officer, Director)in
BoardLucas de Breed(Director)Kat Kayser-Bricker(Director)
Co-investorsConnecticut InnovationsHighCape CapitalPathway BioventuresAdvantage Capital PartnersIronwood Capital
Naveris develops and commercializes liquid biopsy tests for the early detection and monitoring of HPV-associated cancers, particularly head and neck and anal cancers.
BiotechData & InfrastructureDigital HealthHealthtechMedical DevicesWaltham, US
James McNally(Executive Officer, Director)inPiyush Gupta(Executive Officer, Director)
BoardAnne Stone(Director)Francis Crispino(Director)Philip Grahame Haydon(Director)
Co-investorsGurnet Point CapitalTechU Ventures
Nusano produces medical radioisotopes for use in theranostic compounds and cancer treatment applications.
BiotechDeep TechHealthtechMedical DevicesWest Valley City, US
Howard C. Lewin(Co-founder & Chief Product Development Officer)inGlenn B. Rosenthal(Co-founder & Chief Technology Officer)in
Co-investorsWasatch Equity PartnersSection 32S32
TippingPoint Biosciences is a therapeutics company developing a drug discovery platform that targets unstructured regions in chromatin proteins to treat diseases caused by dysfunctional genome chromatin packaging, with a focus on cancer.
BiotechDeep TechHealthtechSan Francisco, US
Laura Hsieh(Founder & CEO)in
Co-investorsFREEFLOWSazzeSOSVStoryHouseXEIA Venture Partners
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Paradigm Health
Portfolio news
latest coverage across their companiesCellCentric · finsmes.com · May 6, 2026
TippingPoint Biosciences · trysignalbase.com · Apr 2, 2026
Frequently asked questions
- How many investments has BrightEdge made?
- BrightEdge has 9 tracked investments, including 3 dated in the last 24 months.
- What stage does BrightEdge invest at?
- BrightEdge invests at the Pre-Seed, Seed, Series A, Series B, Late Stage stages.
- What sectors does BrightEdge focus on?
- BrightEdge focuses on Biotech, Digital Health, Healthtech, Impact & Social Good, Medical Devices.
- Where is BrightEdge located?
- BrightEdge is headquartered in Atlanta, US.
Images
Similar investors
Novo Holdings is the holding and investment company that manages the assets of the Novo Nordisk Foundation, serving as controlling shareholder of Novo Nordisk and Novonesis. It invests in life science companies across all stages and manages a diversified portfolio of equities, bonds, real estate, infrastructure and private equity.
Sofinnova Partners is a life sciences venture capital firm investing across the value chain from seed to later stage, with a focus on healthcare and sustainability. It backs companies in biopharma, medtech, digital medicine, agriculture and industrial processes.
Artesian is a deep tech and hardware venture capital investor that builds funds around specific institutional backers — governments, corporations, universities, industry bodies and super funds — to pursue both financial returns and strategic outcomes in critical industries.
Lundbeckfonden is a Danish foundation that funds health-science research (with a focus on the brain) and invests in and owns healthcare and biotech companies. Its BioCapital arm supports commercialization of biotech science in Denmark and internationally.